The Ipsen share is coming back to a technical support zone comprising the lower bound of the trading range. This provides a good timing to go long on the stock. Investors have an opportunity to buy the stock and target the € 103.7.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 92 EUR in weekly data.
The close medium term support offers good timing for purchasing the stock.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company is in a robust financial situation considering its net cash and margin position.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
With an enterprise value anticipated at 3.34 times the sales for the current fiscal year, the company turns out to be overvalued.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last few months, analysts have been revising downwards their earnings forecast.
The technical configuration over the long term remains negative on the weekly chart below the resistance level at 120 EUR
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.